Yield10 Bioscience, Inc. (YTEN): Price and Financial Metrics


Yield10 Bioscience, Inc. (YTEN): $8.54

-0.44 (-4.90%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add YTEN to Watchlist
Sign Up

Industry: Agriculture


Ranked

of NR

in industry

YTEN Stock Summary

  • Yield10 Bioscience Inc's market capitalization of $7,636,600 is ahead of just 4.47% of US-listed equities.
  • YTEN's price/sales ratio is 11.69; that's higher than the P/S ratio of 91.14% of US stocks.
  • Shareholder yield, a measure of how much is returned to shareholders via dividends and share repurchases, for YTEN comes in at -33.82% -- higher than that of just 10.81% of stocks in our set.
  • Stocks that are quantitatively similar to YTEN, based on their financial statements, market capitalization, and price volatility, are PTCT, RTRX, MRAM, XXII, and ZNGA.
  • YTEN's SEC filings can be seen here. And to visit Yield10 Bioscience Inc's official web site, go to www.yield10bio.com.

YTEN Stock Price Chart Interactive Chart >

Price chart for YTEN

YTEN Price/Volume Stats

Current price $8.54 52-week high $23.49
Prev. close $8.98 52-week low $4.16
Day low $8.53 Volume 33,600
Day high $9.01 Avg. volume 173,498
50-day MA $8.99 Dividend yield N/A
200-day MA $9.55 Market Cap 41.58M

Yield10 Bioscience, Inc. (YTEN) Company Bio


Yield10 Bioscience, Inc. is an agricultural bioscience company, which focuses on the development of technologies to produce step-change improvements in crop yield for food and feed crops to enhance global food security. The company was founded by Anthony J. Sinskey, Simon F. Williams and Oliver P. Peoples in June 1992 and is headquartered in Woburn, MA.


YTEN Latest News Stream


Event/Time News Detail
Loading, please wait...

YTEN Latest Social Stream


Loading social stream, please wait...

View Full YTEN Social Stream

Latest YTEN News From Around the Web

Below are the latest news stories about Yield10 Bioscience Inc that investors may wish to consider to help them evaluate YTEN as an investment opportunity.

Yield10 Bioscience (YTEN) Presents At Benzinga Biotech Small Cap Virtual Conference - Slideshow

The following slide deck was published by Yield10 Bioscience, Inc. in conjunction with this event....

SA Transcripts on Seeking Alpha | March 26, 2021

Yield10 Bioscience's (YTEN) CEO Oliver Peoples on Q4 2020 Results - Earnings Call Transcript

Yield10 Bioscience, Inc. (YTEN) Q4 2020 Earnings Conference Call March 16, 2021 04:30 PM ET Company Participants Lynne Brum – Vice President-Planning and Corporate Communications Oliver Peoples – President and Chief Executive Officer Kristi Snell – Vice President of Research and Chief Science Officer Conference Call Participants Anthony Vendetti –...

SA Transcripts on Seeking Alpha | March 17, 2021

Read More 'YTEN' Stories Here

YTEN Price Returns

1-mo 4.40%
3-mo -45.12%
6-mo 45.24%
1-year 29.98%
3-year -86.05%
5-year -97.08%
YTD 47.75%
2020 -15.74%
2019 -79.34%
2018 -53.11%
2017 -49.43%
2016 -77.27%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.819 seconds.